User profiles for Gianfranco Ferraccioli
g ferraccioliProfessor of Rheumatology, Universita' Cattolica del Sacro Cuore, Roma Verified email at unicatt.it Cited by 40331 |
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
…, M Dougados, P Emery, G Ferraccioli… - Arthritis & …, 2010 - Wiley Online Library
Objective The 1987 American College of Rheumatology (ACR; formerly, the American
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized …
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including …
…, M Dougados, P Emery, G Ferraccioli… - Annals of the …, 2007 - ard.bmj.com
Objective: To formulate EULAR recommendations for the management of early arthritis.
Methods: In accordance with EULAR’s “standardised operating procedures”, the task force …
Methods: In accordance with EULAR’s “standardised operating procedures”, the task force …
[HTML][HTML] Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study
…, GR Burmester, J Devlin, G Ferraccioli… - Arthritis research & …, 2008 - Springer
Introduction We analyzed the prevalence of cardiovascular (CV) disease in patients with
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of …
rheumatoid arthritis (RA) and its association with traditional CV risk factors, clinical features of …
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis
Immune-regulatory mechanisms of drug-free remission in rheumatoid arthritis (RA) are
unknown. We hypothesized that synovial tissue macrophages (STM), which persist in remission, …
unknown. We hypothesized that synovial tissue macrophages (STM), which persist in remission, …
2016 update of the EULAR recommendations for the management of early arthritis
…, M Dougados, P Emery, G Ferraccioli… - Annals of the …, 2017 - ard.bmj.com
Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis, …
been presented, considerable research has been published in the field of early arthritis, …
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
…, G Burmester, T Dörner, G Ferraccioli… - Annals of the …, 2011 - ard.bmj.com
Background Since initial approval for the treatment of rheumatoid arthritis (RA), rituximab has
been evaluated in clinical trials involving various populations with RA. Information has also …
been evaluated in clinical trials involving various populations with RA. Information has also …
Efficacy and safety of rituximab in type II mixed cryoglobulinemia
…, M Baccarani, R Fanin, G Ferraccioli - Blood, The Journal …, 2003 - ashpublications.org
The best treatment of type II mixed cryoglobulinemia (MC) has still to be defined. Antiviral
treatment for the frequent underlying infectious trigger hepatitis C virus (HCV) may be …
treatment for the frequent underlying infectious trigger hepatitis C virus (HCV) may be …
EULAR definition of difficult-to-treat rheumatoid arthritis
…, Y Prior, E Nikiphorou, G Ferraccioli… - Annals of the …, 2021 - ard.bmj.com
Background Despite treatment according to the current management recommendations, a
significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These …
significant proportion of patients with rheumatoid arthritis (RA) remain symptomatic. These …
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open‐label extension analysis
…, A Baldassare, G Ferraccioli… - … : Official Journal of …, 2007 - Wiley Online Library
Objective To determine the safety and efficacy of additional courses of rituximab in patients
with rheumatoid arthritis (RA). Methods An open‐label extension analysis of RA patients …
with rheumatoid arthritis (RA). Methods An open‐label extension analysis of RA patients …
Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells
…, AD Candia, R Fanin, G Ferraccioli - Arthritis & …, 2002 - Wiley Online Library
Objective The pathogenetic role of B cells in rheumatoid arthritis (RA) is under debate, but it
is currently believed to be marginal. The availability of selective anti–B cell treatment …
is currently believed to be marginal. The availability of selective anti–B cell treatment …